1.Dual source CT coronary angiography and selective coronary angiography for evaluation of coronary artery stenosis: a control study
Feng XU ; Yuanyuan BO ; Baoming ZOU ; Qinyan HU ; Zhengyi BAO ; Jingwu WANG ; Min XU
Journal of Interventional Radiology 2015;24(12):1044-1046
Objective To evaluate the diagnostic accuracy of dual source CT angiography (DSCTA) for coronary artery stenosis.Methods During the period from November 2012 to November 2013, a total of 210 patients with coronary artery disease underwent DSCTA and selective coronary arteriography (CAG). Taking CAG as the gold standard, the diagnostic accuracy of DSCTA for coronary artery stenosis was evaluated. Thirty patients receiving DSCTA and 30 patients receiving CAG were selected, and all of them underwent stent implantation in the anterior descending branch after imaging examination. The angiography positions, the used time of PCI and the used dosage of contrast agent were compared between the two groups. Results DSCTA was performed in 210 patients and a total of 2 630 segments of coronary stenosis or occlusion were detected. Compared with CAG, the diagnostic sensitivity, specificity, positive predictive value and negative predictive value of DSCTA were 95.4%, 96.2%, 91.3%and 100%respectively, which were not significantly different from those obtained by CAG (P=0.066). In performing DSCTA, 2-3 angiography positions were used (2-4 positions less than that of CAG), the used time of PCI was about 15 min (about 10 min less than that of CAG), and the mean used dosage of contrast agent was 48 ml (30-150 ml) (about half less than that of CAG). Conclusion DSCTA has higher accuracy in diagnosing coronary artery stenosis, quite similar to that of CAG. DSCTA is a safe, reliable and noninvasive examination method. Preoperative DSCTA can reduce exposure positions during angiography, can reduce the dosage of contrast agent, and can shorten the time of PCI as well, thus, iatrogenic radioactive radiation dose can be reduced.
2.Analysis of body composition in patients with Crohn's disease.
Ting YAN ; Lingling LI ; Qinyan WU ; Xiang GAO ; Pinjin HU ; Qing HE
Chinese Journal of Gastrointestinal Surgery 2014;17(10):981-984
OBJECTIVETo investigate the differences in body composition between Crohn's disease(CD) patients and healthy subjects as well as the characteristics of human body composition in various types of CD.
METHODSA total of 57 CD patients were prospectively selected from the Sixth Affiliated Hospital of Sun Yat-sen University as the study group, while 51 healthy subjects as the control group. Protein content, mineral content, fat content, lean body mass, waist circumference, and hip circumference in the two groups were measured by body composition analyzer. Characteristics of CD at different location and different disease activity index were investigated as well.
RESULTSIntracellular fluid, extracellular fluid, weight, protein content, fat content, lean body mass, muscle weight, body fat ratio, waist hip ratio, body weight ratio, arm muscle circumference, arm circumference, quality of cells, BMI and basal metabolic rate in CD patients were significantly lower than those in control group(all P<0.05). Proportion of protein-deficiency patients and fat-deficiency patients were 66.7% and 47.4% respectively. Protein content, fat content, and lean body mass in ileocolic CD patients were lower than those with small bowel and colonic CD(all P<0.05). Protein content, fat content, lean body mass in patients with high disease activity index were lower than those in patients with low and medium index, but higher basal metablic rate was found in the former group(all P<0.05).
CONCLUSIONSThe human body composition in patients with CD are different from healthy people. Disease location and disease activity index have an impact on protein content, fat content, and lean body mass.
Adipose Tissue ; Body Composition ; Body Weight ; Crohn Disease ; physiopathology ; Humans
3.Risk factors for venous thrombosis associated with peripherally inserted central catheters in lymphoma patients undergoing chemotherapy
Hua GUO ; Qinyan SHANG ; Xiaojing HU ; Yi LU
Chinese Journal of Modern Nursing 2022;28(8):1080-1083
Objective:To investigate the risk factors of venous thrombosis associated with peripherally inserted central catheter (PICC) in lymphoma patients undergoing chemotherapy.Methods:Using the convenient sampling method, a total of 135 patients with lymphoma undergoing chemotherapy who were admitted to Department of Oncology in Xinxiang Central Hospital from September 2019 to September 2020 were selected as the research objects. According to the occurrence of PICC-related venous thrombosis, they were divided into the thrombosis group ( n=23) and the non-thrombotic group ( n=112) . The general data, PICC catheter vein, catheter tip position, PICC catheter limb and other data were collected. Binomial Logistic regression analysis was used to analyze the risk factors of PICC-related venous thrombosis. Results:The incidence of PICC-related venous thrombosis in lymphoma patients undergoing chemotherapy was 17.04% (23/135) . Binomial logistic regression analysis showed that the catheterized vein was the cephalic vein, the catheter tip was located within the upper 2/3 of the superior vena cava, and the ratio of catheter diameter divided by vein diameter greater than or equal to 67% were independent risk factors of PICC-related venous thrombosis in lymphoma chemotherapy patients ( P<0.01) . Conclusions:The risk factors of PICC-related venous thrombosis in lymphoma chemotherapy patients mainly include the cephalic vein, the catheter tip within the upper 2/3 of the superior vena cava and the ratio of catheter diameter to vein diameter greater than or equal to 67%.Nursing staff should focus on high-risk population and actively take interventions to reduce the incidence of PICC-related venous thrombosis.
4.Analysis of body composition in patients with Crohn′s disease
Ting YAN ; Lingling LI ; Qinyan WU ; Xiang GAO ; Pinjin HU ; Qing HE
Chinese Journal of Gastrointestinal Surgery 2014;(10):981-984
Objective To investigate the differences in body composition between Crohn′s disease (CD) patients and healthy subjects as well as the characteristics of human body composition in various types of CD. Methods A total of 57 CD patients were prospectively selected from the Sixth Affiliated Hospital of Sun Yat-sen University as the study group, while 51 healthy subjects as the control group. Protein content, mineral content, fat content, lean body mass, waist circumference, and hip circumference in the two groups were measured by body composition analyzer. Characteristics of CD at different location and different disease activity index were investigated as well. Results Intracellular fluid, extracellular fluid, weight, protein content, fat content, lean body mass, muscle weight, body fat ratio, waist hip ratio, body weight ratio, arm muscle circumference, arm circumference, quality of cells, BMI and basal metabolic rate in CD patients were significantly lower than those in control group (all P<0.05). Proportion of protein-deficiency patients and fat-deficiency patients were 66.7% and 47.4% respectively. Protein content, fat content, and lean body mass in ileocolic CD patients were lower than those with small bowel and colonic CD (all P<0.05). Protein content, fat content, lean body mass in patients with high disease activity index were lower than those in patients with low and medium index, but higher basal metablic rate was found in the former group (all P<0.05). Conclusions The human body composition in patients with CD are different from healthy people. Disease location and disease activity index have an impact on protein content, fat content, and lean body mass.
5.Analysis of body composition in patients with Crohn′s disease
Ting YAN ; Lingling LI ; Qinyan WU ; Xiang GAO ; Pinjin HU ; Qing HE
Chinese Journal of Gastrointestinal Surgery 2014;(10):981-984
Objective To investigate the differences in body composition between Crohn′s disease (CD) patients and healthy subjects as well as the characteristics of human body composition in various types of CD. Methods A total of 57 CD patients were prospectively selected from the Sixth Affiliated Hospital of Sun Yat-sen University as the study group, while 51 healthy subjects as the control group. Protein content, mineral content, fat content, lean body mass, waist circumference, and hip circumference in the two groups were measured by body composition analyzer. Characteristics of CD at different location and different disease activity index were investigated as well. Results Intracellular fluid, extracellular fluid, weight, protein content, fat content, lean body mass, muscle weight, body fat ratio, waist hip ratio, body weight ratio, arm muscle circumference, arm circumference, quality of cells, BMI and basal metabolic rate in CD patients were significantly lower than those in control group (all P<0.05). Proportion of protein-deficiency patients and fat-deficiency patients were 66.7% and 47.4% respectively. Protein content, fat content, and lean body mass in ileocolic CD patients were lower than those with small bowel and colonic CD (all P<0.05). Protein content, fat content, lean body mass in patients with high disease activity index were lower than those in patients with low and medium index, but higher basal metablic rate was found in the former group (all P<0.05). Conclusions The human body composition in patients with CD are different from healthy people. Disease location and disease activity index have an impact on protein content, fat content, and lean body mass.
6.Analysis and Treatment of Liver Function Injury Caused by Positive Control Drug Heparin Sodium in Early Clinical Studies of New Drugs
ZHANG Wei ; YANG Dandan ; HU Yin ; WANG Xiaodan ; DUAN Yi ; LI Qinyan ; WANG Zhiyang ; JIANG Bo
Chinese Journal of Modern Applied Pharmacy 2023;40(19):2728-2831
OBJECTIVE To report the analysis and treatment of liver function injury caused by heparin sodium injection in the positive control group in an early clinical study of new drugs, in order to provide reference for the clinical use of heparin sodium injection and provide ideas for the treatment of adverse reactions. METHODS Analyzed and summarized one case of liver injury in a tolerance and pharmacokinetics study of a new anticoagulant drug with both placebo and heparin sodium as control, described the case process, analyzed the cause, and discussed the enlightenment for treatment of adverse event in early clinical research and the safety of heparin sodium in clinical use. RESULTS Three cases occurred different degrees increasing of alanine aminotransferase and aspartate aminotransferase after 4 healthy subjects were infused with heparin sodium for 5 consecutive days. It was considered that those were adverse reactions caused by heparin sodium. Timely treatment was performed by strengthening monitoring and administrating liver protective drugs. Protocol was revised to avoid further injury to the follow-up subjects. CONCLUSION Continuous infusion of heparin sodium injection can easily cause liver function damage, and should be given sufficient attention during clinical use. Early clinical research should promptly analyze and handle adverse reactions to ensure the safety of subjects.